ArticleActa pharmaceutica Sinica. B2025

Improved prebiotic-based "shield" equipped probiotics for enhanced colon cancer therapy by polarizing M1 macrophages and regulating intestinal microbiota.

Yang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.